The landscape of dementia diagnosis has developed considerably with the advent of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent tests that may detect Alzheimer's pathology many years before signs emerge. Though these technological innovations stand for exceptional progress in comprehension neurodegenerativ